Allarta’s technology is focused in three areas.
Proprietary Immune-Privileged Polymer Platform
Empowering
Safe, Durable, Retrievable Therapy
Next-Gen Microgels
Enabling
Therapeutic Cells & Medicines
RT-Vaccine Delivery Platform
Disrupting
Cold Chain Logistics
Proprietary platform
Our Technology Pipeline
